Loeillot Olivier

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Loeillot Olivier's trades of Repligen Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Repligen Corp (RGEN)
Transaction date
Planned sale
Price
493.22
Quantity 21,987 +14.7%
Value US$3,687,015
US Repligen Corp (RGEN)
Transaction date
Planned sale
Price
404.44
Quantity 81,611 +32.5%
Value US$4,314,170
US Repligen Corp (RGEN)
Transaction date
Proposed sale
Price
378.41
Quantity 74,090
Value US$4,167,072
US Repligen Corp (RGEN)
Transaction date
Proposed sale
Price
178.75
Quantity 1,333
Value US$238,274
US Repligen Corp (RGEN)
Transaction date
Planned sale
Price
190.00
Quantity 4,542 -8.6%
Value US$862,980
US Repligen Corp (RGEN)
Transaction date
Planned sale
Price
190.00
Quantity 8,404 -14.8%
Value US$1,596,760
US Repligen Corp (RGEN)
Transaction date
Proposed sale
Price
190.00
Quantity 12,946
Value US$2,459,740
US Repligen Corp (RGEN)
Transaction date
Planned sale
Price
180.00
Quantity 5,426 -10.1%
Value US$976,680
US Repligen Corp (RGEN)
Transaction date
Proposed sale
Price
180.00
Quantity 5,426
Value US$976,680
US Repligen Corp (RGEN)
Transaction date
Planned sale
Price
165.90
Quantity 3,035 -5.9%
Value US$503,506
US Repligen Corp (RGEN)
Transaction date
Proposed sale
Price
165.90
Quantity 3,035
Value US$503,506
US Repligen Corp (RGEN)
Transaction date
Planned sale
Price
180.00
Quantity 5,426 -9.1%
Value US$976,680
US Repligen Corp (RGEN)
Transaction date
Proposed sale
Price
180.00
Quantity 5,426
Value US$976,680
US Repligen Corp (RGEN)
Transaction date
Sale
Price
140.00
Quantity 3,832 -6.6%
Value US$536,480
US Repligen Corp (RGEN)
Transaction date
Proposed sale
Price
140.00
Quantity 3,832
Value US$536,480
US Repligen Corp (RGEN)
Transaction date
Sale
Price
170.00
Quantity 7,041 -16.4%
Value US$1,196,970
US Repligen Corp (RGEN)
Transaction date
Proposed sale
Price
170.00
Quantity 7,041
Value US$1,196,970
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-06 2026-10-05
US Repligen Corp (RGEN)
PlS Planned sale
21,987 +14.7%
493.22
US$3,687,015 		21,987 +14.7% 493.22 US$3,687,015
2026-10-06 2026-10-05
US Repligen Corp (RGEN)
PlS Planned sale
81,611 +32.5%
404.44
US$4,314,170 		81,611 +32.5% 404.44 US$4,314,170
2026-10-05 2026-10-05
US Repligen Corp (RGEN)
PrS Proposed sale
74,090
378.41
US$4,167,072 		74,090 378.41 US$4,167,072
2026-10-05 2026-10-05
US Repligen Corp (RGEN)
PrS Proposed sale
1,333
178.75
US$238,274 		1,333 178.75 US$238,274
2026-09-25 2026-09-24
US Repligen Corp (RGEN)
PlS Planned sale
4,542 -8.6%
190.00
US$862,980 		4,542 -8.6% 190.00 US$862,980
2026-09-25 2026-09-24
US Repligen Corp (RGEN)
PlS Planned sale
8,404 -14.8%
190.00
US$1,596,760 		8,404 -14.8% 190.00 US$1,596,760
2026-09-24 2026-09-24
US Repligen Corp (RGEN)
PrS Proposed sale
12,946
190.00
US$2,459,740 		12,946 190.00 US$2,459,740
2026-09-22 2026-09-21
US Repligen Corp (RGEN)
PlS Planned sale
5,426 -10.1%
180.00
US$976,680 		5,426 -10.1% 180.00 US$976,680
2026-09-21 2026-09-21
US Repligen Corp (RGEN)
PrS Proposed sale
5,426
180.00
US$976,680 		5,426 180.00 US$976,680
2026-09-08 2026-09-04
US Repligen Corp (RGEN)
PlS Planned sale
3,035 -5.9%
165.90
US$503,506 		3,035 -5.9% 165.90 US$503,506
2026-09-04 2026-09-04
US Repligen Corp (RGEN)
PrS Proposed sale
3,035
165.90
US$503,506 		3,035 165.90 US$503,506
2026-08-21 2026-08-20
US Repligen Corp (RGEN)
PlS Planned sale
5,426 -9.1%
180.00
US$976,680 		5,426 -9.1% 180.00 US$976,680
2026-08-20 2026-08-20
US Repligen Corp (RGEN)
PrS Proposed sale
5,426
180.00
US$976,680 		5,426 180.00 US$976,680
2026-04-22 2026-04-21
US Repligen Corp (RGEN)
S Sale
3,832 -6.6%
140.00
US$536,480 		3,832 -6.6% 140.00 US$536,480
2026-04-21 2026-04-21
US Repligen Corp (RGEN)
PrS Proposed sale
3,832
140.00
US$536,480 		3,832 140.00 US$536,480
2025-11-26 2025-11-25
US Repligen Corp (RGEN)
S Sale
7,041 -16.4%
170.00
US$1,196,970 		7,041 -16.4% 170.00 US$1,196,970
2025-11-25 2025-11-25
US Repligen Corp (RGEN)
PrS Proposed sale
7,041
170.00
US$1,196,970 		7,041 170.00 US$1,196,970